Shanghai Haoyuan Chemexpress Co (SHSE:688131) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688131 Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
92 GF Score
Price ¥70.55
GF Value ¥65.89
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai Haoyuan Chemexpress Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688131
92GF Score
Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued. The current stock price of ¥70.55 is trading 7.1% above its estimated GF Value™ of ¥65.89. GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Fairly Valued.

Key valuation signals for SHSE:688131:

  • FFO:
  • GF Value™: ¥65.89 vs. price of ¥70.55 (7.1% above fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Haoyuan Chemexpress Co Business Description

Address No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
92GF Score

Get the complete analysis for SHSE:688131

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥70.55
Price
¥65.89
GF Value